• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转铁蛋白-阿霉素偶联物对蒽环类耐药细胞的细胞毒性

Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells.

作者信息

Fritzer M, Barabas K, Szüts V, Berczi A, Szekeres T, Faulk W P, Goldenberg H

机构信息

Institut für Medizinische Chemie, University of Vienna, Austria.

出版信息

Int J Cancer. 1992 Oct 21;52(4):619-23. doi: 10.1002/ijc.2910520421.

DOI:10.1002/ijc.2910520421
PMID:1399145
Abstract

Conjugates of adriamycin coupled to transferrin by glutaraldehyde are cytotoxic to human promyelocytic (HL-60) and erythroleukemic (K562) cells. Growth inhibition of adriamycin-sensitive cells, as evaluated by thymidine incorporation and the MTT-assay, was higher for conjugates than for free adriamycin. The cytotoxicity toward adriamycin-resistant K562 and HL-60 cells was 3-fold and more than 10-fold higher, respectively, for the transferrin-adriamycin conjugate than for the free drug. The effect of the conjugate was dependent on its adriamycin content, i.e., on its conjugation number.

摘要

通过戊二醛将阿霉素与转铁蛋白偶联而成的结合物对人早幼粒细胞(HL - 60)和红白血病细胞(K562)具有细胞毒性。通过胸腺嘧啶核苷掺入法和MTT法评估,结合物对阿霉素敏感细胞的生长抑制作用比对游离阿霉素更强。转铁蛋白 - 阿霉素结合物对阿霉素耐药的K562和HL - 60细胞的细胞毒性分别比游离药物高3倍和10倍以上。结合物的作用取决于其阿霉素含量,即其偶联数。

相似文献

1
Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells.转铁蛋白-阿霉素偶联物对蒽环类耐药细胞的细胞毒性
Int J Cancer. 1992 Oct 21;52(4):619-23. doi: 10.1002/ijc.2910520421.
2
Transferrin-adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells.抑制肿瘤细胞增殖而不与DNA相互作用的转铁蛋白-阿霉素偶联物可抑制K562细胞中的质膜氧化还原酶和质子释放。
Biochem Int. 1991 Dec;25(5):815-22.
3
Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells.人转铁蛋白的阿霉素缀合物可结合转铁蛋白受体并杀死K562和HL60细胞。
Arch Biochem Biophys. 1993 Jan;300(1):356-63. doi: 10.1006/abbi.1993.1048.
4
Characterization of the anti-cancer activity of transferrin-adriamycin conjugates.转铁蛋白-阿霉素偶联物抗癌活性的表征
Am J Reprod Immunol. 1992 Apr-May;27(3-4):163-6. doi: 10.1111/j.1600-0897.1992.tb00744.x.
5
Evidence in support of the plasma membrane as the target for transferrin-adriamycin conjugates in K562 cells.支持转铁蛋白-阿霉素偶联物在K562细胞中以质膜为作用靶点的证据。
Am J Reprod Immunol. 1991 Apr;25(3):120-3. doi: 10.1111/j.1600-0897.1991.tb01078.x.
6
Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients.转铁蛋白-阿霉素偶联物用于急性白血病患者药物递送的初步临床研究。
Mol Biother. 1990 Mar;2(1):57-60.
7
Quantitative morphological analysis of adriamycin-resistant human K562 leukemic cells.阿霉素耐药的人K562白血病细胞的定量形态学分析
Cytometry. 1989 Jan;10(1):37-43. doi: 10.1002/cyto.990100107.
8
Cytotoxic effect of the protein-doxorubicin conjugates on the multidrug-resistant human myelogenous leukemia cell line, K562, in vitro.蛋白质-阿霉素缀合物对多药耐药人髓性白血病细胞系K562的体外细胞毒性作用。
Tumour Biol. 1993;14(5):288-94. doi: 10.1159/000217841.
9
Adriamycin resistance is characterized by ultrastructural changes in human leukaemic K562 cells in vitro.阿霉素耐药性的特征在于体外培养的人白血病K562细胞的超微结构变化。
Biol Cell. 1992;74(3):287-97. doi: 10.1016/0248-4900(92)90040-8.
10
Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.转铁蛋白作为药物载体:阿霉素-转铁蛋白缀合物在人白血病细胞中的细胞毒性、细胞摄取和转运动力学。
Toxicol In Vitro. 2014 Mar;28(2):187-97. doi: 10.1016/j.tiv.2013.09.013. Epub 2013 Sep 19.

引用本文的文献

1
The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?自噬与铁死亡之间的相互作用:我们能从中学到什么来靶向癌症中的耐药性?
Cancer Biol Med. 2019 Nov;16(4):630-646. doi: 10.20892/j.issn.2095-3941.2019.0158.
2
Cancer Targeting and Drug Delivery Using Carbon-Based Quantum Dots and Nanotubes.基于碳量子点和纳米管的癌症靶向和药物传递。
Molecules. 2018 Feb 10;23(2):378. doi: 10.3390/molecules23020378.
3
Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.
克服多药耐药性的蒽环类纳米给药系统:综述
Nano Today. 2013 Jun 1;8(3):313-331. doi: 10.1016/j.nantod.2013.04.006.
4
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.转铁蛋白受体与抗癌治疗药物的靶向递送
Biochim Biophys Acta. 2012 Mar;1820(3):291-317. doi: 10.1016/j.bbagen.2011.07.016. Epub 2011 Aug 5.
5
Biomechanics and biophysics of cancer cells.癌细胞的生物力学与生物物理学
Acta Biomater. 2007 Jul;3(4):413-38. doi: 10.1016/j.actbio.2007.04.002. Epub 2007 May 30.
6
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.新型核糖核苷酸还原酶抑制剂三甲氧苄二氨嘧啶的生化及抗肿瘤活性
Cancer Chemother Pharmacol. 1994;34(1):63-6. doi: 10.1007/BF00686113.
7
Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines.对游离和聚合物结合蒽环类药物细胞内蓄积的直接评估。
Cancer Chemother Pharmacol. 1995;35(6):501-5. doi: 10.1007/BF00686835.